5,8,11-eicosatriynoic acid has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, WC; Murota, S; Nakao, J; Ooyama, T; Orimo, H | 1 |
König, W; Kroegel, C; Kunau, HW | 1 |
2 other study(ies) available for 5,8,11-eicosatriynoic acid and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
Article | Year |
---|---|
Platelets stimulate aortic smooth muscle cell migration in vitro. Involvement of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Aorta, Thoracic; Arachidonic Acids; Blood Platelets; Cell Differentiation; Cell Movement; Fatty Acids, Unsaturated; Indomethacin; Male; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Count; Rats; Rats, Inbred Strains | 1982 |
Inhibition of the eosinophil chemotactic factor (ECF) release from human PMNs and rat mast cells by arachidonic acid analogs.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Chemotactic Factors; Chemotactic Factors, Eosinophil; Eicosanoic Acids; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Mast Cells; Neutrophils; Rats | 1981 |